USPTO Issues Tenon Medical Three U.S. Patents

October 18, 2024

DENVER, Colo., Oct 18, 2024 (247marketnews.com)- Tenon Medical (NASDAQ: TNON) reported that the United States Patent and Trademark Office (USPTO) issued the Company three U.S. patents.

The first two patents, numbers 12,115,075 and 12,115,076, entitled “Sacroiliac Joint Stabilization Prostheses”, are directed to Tenon’s Catamaran prostheses that include unique drug delivery compositions that enhance sealing of the prostheses in SI joint bone structures and bone growth about and within the prostheses when the prostheses are implanted in a SI joint.

The third patent, 12,115,077, is entitled “Systems, Apparatus and Methods for Stabilizing Sacroiliac Joints” and covers SI joint prostheses with unique structures and configurations to correct failed SI joint stabilization with alternative commercial SI joint implants without requiring removal of the failed implant.

Richard Ginn, Tenon Medical’s Co-Founder and Chief Technology Officer, commented, “We are pleased with the USPTO’s recognition of the novel Catamaran® SI joint prostheses that will provide a best-in-class solution to specifically address the need for revision of other ineffective SI joint devices.

“The issuance of these patents reinforces Tenon’s focus on innovation while simultaneously protecting our technology platform which strengthens our competitive position in the industry.”

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (TNON)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.